scholarly journals Tacrolimus Level Variability in Setting of Gastric Sleeve

2021 ◽  
Vol 40 (4) ◽  
pp. S486-S487
Author(s):  
G. Waldman ◽  
J.E. Clark ◽  
C.C. Rogers ◽  
A. Gerlach ◽  
E. Coglianese ◽  
...  
2018 ◽  
Author(s):  
Anca Georgiana Tudurean-Olteanu ◽  
Radu Danila ◽  
Mirela Claudia Nechita ◽  
Andreea-Nicoleta Dumitrascu ◽  
Cristina Preda ◽  
...  

2021 ◽  
Vol 11 (2) ◽  
pp. 90
Author(s):  
Chih-Yang Hsiao ◽  
Ming-Chih Ho ◽  
Cheng-Maw Ho ◽  
Yao-Ming Wu ◽  
Po-Huang Lee ◽  
...  

Tacrolimus is the most widely used immunosuppressant in liver transplant (LT) patients. However, the ideal long-term target level for these patients is unknown. This retrospective study aimed to investigate the impact of tacrolimus blood concentration five years after LT on long-term patient survival outcomes in adult LT recipients. Patients who underwent LT between January 2004 and July 2014 at a tertiary medical center were included in this study (n = 189). The mean tacrolimus blood concentrations of each patient during the fifth year after LT were recorded and the overall survival rate was determined. A multivariate analysis of factors associated with long-term survival was conducted using a Cox’s model. The median follow-up period was 9.63 years, and 144 patients (76.2%) underwent live donor LT. Sixteen patients died within 5 years of LT. In the Cox’s model, patients with a mean tacrolimus blood trough level of 4.6–10.2 ng/mL had significantly better long-term survival than those with a mean tacrolimus blood trough level outside this range (estimated hazard ratio = 4.76; 95% confidence interval: 1.34–16.9, p = 0.016). Therefore, a tacrolimus level no lower than 4.6 ng/mL would be recommended in adult LT patients.


2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Ozan Şen ◽  
Ümit Sekmen ◽  
Ahmet G. Türkçapar ◽  
Mehmet A. Yerdel

Antibiotics ◽  
2018 ◽  
Vol 8 (1) ◽  
pp. 1 ◽  
Author(s):  
Ramy Hanna ◽  
Shih-Fan Sun ◽  
Pryce Gaynor

Carbapenem agents are advanced derivatives of cephalosporins that are active against bacteria that produce extended spectrum beta lactamases (ESBL). These antibiotics are resistant to enzymatic cleavage, and have good central nervous system penetration. Given this fact, it is not surprising that these drugs have been reported to cause neurological side effects like seizures and encephalopathy. We report a case of a patient on hemodialytic support who had a notable change in mentation and vocal tremor. This was at first attributed to calcineurin toxicity, but after the finding of a normal tacrolimus level, ertapenem neurotoxicity was suspected. After discontinuation of the offending agent, the patient’s vocal tremor, cognition, and neurological function returned to baseline levels.


2018 ◽  
Vol 14 (11) ◽  
pp. S78
Author(s):  
Christopher De Jesus ◽  
Julio Teixeira

2020 ◽  
Vol 45 (1) ◽  
pp. 235-246
Author(s):  
Malgorzata M. Brzozowska ◽  
Thach Tran ◽  
Dana Bliuc ◽  
John Jorgensen ◽  
Michael Talbot ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document